Vimarsana
Biggest News Aggregation in the World

Page 7 - Breakthrough Device Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Program Today - Breaking & Trending Today

Silverlon Receives FDA Breakthrough Device Designation for Radiation Dermatitis and Cutaneous Radiation Injury - Vimarsana News

Silverlon Receives FDA Breakthrough Device Designation for Radiation Dermatitis and Cutaneous Radiation Injury

Geneva, ILLINOIS (PRWEB) November 30, 2021 -- Argentum Medical, a medical device leader and pioneer of silver- plated nylon technology, today announced the

Source: prweb.com
FDA grants Breakthrough status for Alzheimer's treatment - Vimarsana News

FDA grants Breakthrough status for Alzheimer's treatment

/PRNewswire/ -- Renew Bioscience, a commercial stage medical technology company, announced it has received Breakthrough Device Designation status from the U.S....

FDA grants Breakthrough status for Alzheimer's treatment - Vimarsana News

FDA grants Breakthrough status for Alzheimer's treatment

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
FDA grants Breakthrough status for Alzheimer's treatment - Vimarsana News

FDA grants Breakthrough status for Alzheimer's treatment

/PRNewswire/ -- Renew Bioscience, a commercial stage medical technology company, announced it has received Breakthrough Device Designation status from the U.S....

Varian's Embozene Is an FDA Breakthrough - Physical Therapy Products - Vimarsana News

Varian's Embozene Is an FDA Breakthrough - Physical Therapy Products

Varian announces that the US Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its Embozene microspheres for genicular artery embolization (GAE) for symptomatic knee osteoarthritis.